Activated Charcoal suspension

OTHER2 trials

Sponsors

Respirent Pharmaceuticals Co Ltd.

Conditions

Bioequivalence

Phase 1

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)

CompletedNCT03894280

Respirent Pharmaceuticals Co Ltd.Bioequivalence

Start: 2019-03-12End: 2019-05-06Updated: 2019-06-05

A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade

CompletedNCT04124094

Respirent Pharmaceuticals Co Ltd.Bioequivalence

Start: 2019-10-01End: 2020-06-09Updated: 2020-07-07